$1.310
-0.029 (-2.24%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Allogene Therapeutics, Inc. (ALLO) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting ALLO is Strong sell.
Allogene Therapeutics, Inc. (ALLO) 20-Day simple moving average is 1.49, while Allogene Therapeutics, Inc. (ALLO) share price is $—, making it Sell.
Allogene Therapeutics, Inc. (ALLO) 60-Day simple moving average is 1.78, while Allogene Therapeutics, Inc. (ALLO) share price is $—, making it Sell.
Technical Analysis for ALLO
AI Technical ALLOAs of 2026-10-17, the technical board for Allogene Therapeutics, Inc. (ALLO) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $1.30 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 26.38, MACD stands at -0.129 (Sell), Stochastic %K stands at 21.868, Stochastic %D stands at 19.297 and CCI stands at -106.07 (Buy).
ALLO trades below the 60-day SMA (1.78) and below the 200-day SMA (1.99). Immediate resistance sits at Classic R1 1.51, then R2 1.64. Support sits at Classic S1 1.23, then S2 1.08.
Allogene Therapeutics, Inc. (ALLO) Support & Resistance Level
Allogene Therapeutics, Inc. (ALLO) Technical Indicators
2026-10-17
| Name | Value |
|---|---|
| RSI_14 | 26.380 |
| STOCHk_14_3_3 | 21.868 |
| STOCHd_14_3_3 | 19.297 |
| CCI_20 | -106.070 |
| AO_5_34 | -0.319 |
| MOM_10 | -0.200 |
| MACD_12_26_9 | -0.129 |
Allogene Therapeutics, Inc. (ALLO) Relative Strength Index (RSI_14) is 26.380, creating a Buy signal.
Allogene Therapeutics, Inc. (ALLO) Stochastic %K is 21.868, creating a Neutral signal.
Allogene Therapeutics, Inc. (ALLO) Stochastic %D is 19.297, creating a Buy signal.
Allogene Therapeutics, Inc. (ALLO) CCI_20 is -106.070, creating a Buy signal.
Allogene Therapeutics, Inc. (ALLO) Awesome Oscillator (AO) is -0.319, creating a Sell signal.
Allogene Therapeutics, Inc. (ALLO) Momentum (MOM) is -0.200, creating a Sell signal.
Allogene Therapeutics, Inc. (ALLO) Moving Average Convergence Divergence (MACD) is -0.129, creating a Sell signal.
Allogene Therapeutics, Inc. (ALLO) Moving Average
2026-10-17
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.308 | Sell |
| MA_10 | 1.369 | Sell |
| MA_20 | 1.489 | Sell |
| MA_60 | 1.784 | Sell |
| MA_200 | 1.992 | Sell |
| MA_250 | 1.858 | Sell |
Allogene Therapeutics, Inc. (ALLO) 5-Day simple moving average is 1.308, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 10-Day simple moving average is 1.369, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 20-Day simple moving average is 1.489, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 60-Day simple moving average is 1.784, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 200-Day simple moving average is 1.992, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
Allogene Therapeutics, Inc. (ALLO) 250-Day simple moving average is 1.858, while Allogene Therapeutics, Inc. (ALLO) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.